Nano Textiles

Trident Texofab Ltd.

TTFL

Market Cap
₹51 Cr.
P/E
72.02

Trident Texofab Ltd.

  • Trident Texofab
  • Vinny Overseas
  • Signoria Creation

FAQs on Trident Texofab Ltd. Shareprice

Trident Texofab has given better returns compared to its competitors.
Trident Texofab has grown at ~-8.12% over the last 2yrs while peers have grown at a median rate of -17.14%

Trident Texofab is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Trident Texofab is 72.83, while 3 year average PE is 70.53.
Also latest EV/EBITDA of Trident Texofab is 16.55 while 3yr average is 31.39.

View FAQ's On Business

Growth Table

  • Trident Texofab Ltd.
  • Vinny Overseas
  • Signoria Creation

Balance Sheet

  • Trident Texofab Ltd.
  • Vinny Overseas
  • Signoria Creation

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Trident Texofab Ltd.
  • Vinny Overseas
  • Signoria Creation

Cash Flow

  • Trident Texofab Ltd.
  • Vinny Overseas
  • Signoria Creation

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Trident Texofab Ltd.
  • Vinny Overseas
  • Signoria Creation

Quarterly Results

  • Trident Texofab Ltd.
  • Vinny Overseas
  • Signoria Creation

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Trident Texofab Ltd. Financials

Balance sheet of Trident Texofab is moderately strong.

Yes, The net debt of Trident Texofab is increasing.
Latest net debt of Trident Texofab is ₹33.49 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹20.29 Crs.

The profit is oscillating.
The profit of Trident Texofab is ₹0.7 Crs for TTM, ₹2.45 Crs for Mar 2025 and ₹1.08 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Trident Texofab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech